NasdaqGS:INDVPharmaceuticals
Why Indivior (INDV) Is Up 5.0% After Raising 2025 Guidance and Returning to Profitability
Indivior recently reported a return to profitability for the second quarter of 2025 and raised its full-year net revenue guidance to a range of US$1.03 billion to US$1.08 billion.
The company's updated outlook and improved earnings performance highlighted a turnaround, with net income reaching US$18 million compared to a net loss in the same period last year.
We'll explore how Indivior's stronger earnings performance and raised guidance reshape its investment narrative with a focus on...